Warning letter
Americair East Bay: warning letter of May 19, 2000
FDA warning letter UCM068448 · San Francisco District Office
Key facts
| Reference number | UCM068448 |
|---|---|
| Company | Americair East Bay |
| Subject | Medical Oxygen / CGMP |
| Issue date | May 19, 2000 |
| Posted date | May 19, 2000 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| CFR sections cited | 21, 211, 211.22, 211.34, 211.165, 211.22(a), 211.25(a), 211.68(a), 211.165(a), 211.125, 211.125(c), 211.180(a) |
| Country | 3 |
| Inspection city | Vacaville |
| Inspection ZIP | 95688-8700 |
| Inspection start date | Apr 7, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: